VIVO News and Press, Meridian Bioscience Inc. From 02/04/22

Gainers: IRadimed IRMD +8%. Meridian Bioscience VIVO +8%. Biofrontera (NASDAQ:BFRI) +6%. Inspira Technologies Oxy (NASDAQ:IINN) +6%. Taysha Gene Therapies (NASDAQ:TSHA) +5%. Losers: Lannett Company (NYSE:LCI) -24%. Vanda Pharmaceuticals (NASDAQ:VNDA) -22%. E...

Meridian Bioscience press release (NASDAQ:VIVO): Q1 Non-GAAP EPS of $0.35. Revenue of $88.3M (-5.0% Y/Y). For further details see: Meridian Bioscience Non-GAAP EPS of $0.35, revenue of $88.3M

MERIDIAN BIOSCIENCE REPORTS SECOND BEST QUARTER IN COMPANY HISTORY PR Newswire CINCINNATI , Feb. 4, 2022 /PRNewswire/ -- Meridian Bioscience, Inc. (NASDAQ: VIVO) today announced financial results for the first quarter ended December 31, 2021 . ...

Meridian Bioscience (NASDAQ:VIVO) is scheduled to announce Q1 earnings results on Friday, February 4th, before market open. The consensus EPS Estimate is $0.27 (-52.6% Y/Y) and the consensus Revenue Estimate is $73.75M (-13.5% Y/Y). Over the last 2 years, VIVO has beaten EPS estimates 88% of ...

Meridian Bioscience Receives Additional NIH Award to Support the Rapid Development of the Revogene® Molecular Viral Respiratory Testing Panel PR Newswire CINCINNATI , Jan. 31, 2022 /PRNewswire/ -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading global pr...

Meridian Bioscience Launches Lyo-Ready™ qPCR Saliva-Specific Master Mixes for DNA & RNA Direct Detection Meridian Bioscience Launches Lyo-Ready™ qPCR Saliva-Specific Master Mixes for DNA & RNA Direct Detection PR Newswire CINCINNATI , ...

Meridian Bioscience Elects John C. McIlwraith New Chairman of the Board PR Newswire CINCINNATI , Jan. 27, 2022 /PRNewswire/ -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading global provider of diagnostic testing solutions and life science raw materials,...

Meridian Bioscience to Hold First Quarter 2022 Financial Results Conference Call on February 4, 2022 PR Newswire CINCINNATI , Jan. 10, 2022 /PRNewswire/ -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading global provider of diagnostic testing solutions a...

Meridian Bioscience Receives FDA-Clearance for the Curian® Campy Assay PR Newswire CINCINNATI , Jan. 5, 2022 /PRNewswire/ -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading global provider of diagnostic testing solutions and life science raw material...

Meridian Bioscience to Participate in the 2022 H. C. Wainwright Bioconnect Virtual Conference PR Newswire CINCINNATI , Jan. 4, 2022 /PRNewswire/ -- Meridian Bioscience, Inc. (NASDAQ: VIVO) a provider of diagnostic testing solutions and life science raw materials,...